AFP and hepatocellular carcinoma: Additional biomarkers, such as des‐γ carboxyprothrombin and the L3 fraction of AFP, did not improve the early diagnosis of HCC due to low sensitivity and specificity as well as the fact that they are frequently linked to advanced clinical symptoms of HCC.7, 8